Surfactant proteins anti-surfactant antibodies sera infants respiratory distress syndrome surfactant treatment presence surfactant protein antigenemia surfactant protein antibodies serum surfactant-treated control infants respiratory distress syndrome prospective clinical trial surfactant treatment surfactant TA surfactant proteins SPs SP-A Enzyme-linked immunosorbent assays ELISAs surfactant-associated proteins ELISAs IgG IgM surfactant proteins sera infants treatment week age months age significant differences average values surfactant-treated control groups time period control group results ELISAs SP-A IgM antibodies SP-A SP-B significant differences pretreatment sera sera week age significant differences averaged results IgG Positive ELISA values control group surfactant-treated group regard SP-A IgM SP-A SP-B sera neonates week age positive ELISA values sera infants months age patients severe respiratory distress syndrome surfactant circulation transient low titers IgM antibody occurrence surfactant treatment Surfactant treatment leak surfactant proteins vascular space lung damage 